Superiority of intramuscular route and full length glycoprotein D for DNA vaccination against herpes simplex 2. Enhancement of protection by the co-delivery of the GM-CSF gene

By Flo  

Vaccine, Vol. 18, Iss. 28, 2000-08 ,pp. : 3242-3253

Elsevier

Access to resources Recommend Favorite

Immunogenicity of a DNA vaccine against herpes B virus in mice and rhesus macaques

By Loomis-Huff J.E.   Eberle R.   Lockridge K.M.   Rhodes G.   Barry P.A.  

Vaccine, Vol. 19, Iss. 32, 2001-09 ,pp. : 4865-4873

Elsevier

Access to resources Recommend Favorite

Engineering DNA vaccines via co-delivery of co-stimulatory molecule genes

By Kim J.J.   Nottingham L.K.   Wilson D.M.   Bagarazzi M.L.   Tsai A.   Morrison L.D.   Javadian A.   Chalian A.A.   Agadjanyan M.G.   Weiner D.B.  

Vaccine, Vol. 16, Iss. 19, 1998-11 ,pp. : 1828-1835

Elsevier

Access to resources Recommend Favorite

Immunological properties of a DNA plasmid encoding a chimeric protein of herpes simplex virus type 2 glycoprotein B and glycoprotein D

By Domingo C.   Gadea I.   Pardeiro M.   Castilla C.   Fernandez S.   Fernandez-Clua M.A.   De la Cruz Troca J.J.   Punzon C.   Soriano F.   Fresno M.   Tabares E.  

Vaccine, Vol. 21, Iss. 25, 2003-09 ,pp. : 3565-3574

Elsevier

Access to resources Recommend Favorite

DNA immunization utilizing a herpes simplex virus type 2 myogenic DNA vaccine protects mice from mortality and prevents genital herpes

By Gebhard J.R.J.R.   Zhu J.   Cao X.   Minnick J.   Araneo A.B.A.  

Vaccine, Vol. 18, Iss. 17, 2000-03 ,pp. : 1837-1846

Elsevier

Access to resources Recommend Favorite